Helicobacter pylori infection and fasting plasma glucose concentration
- PMID: 11376021
- PMCID: PMC1731446
- DOI: 10.1136/jcp.54.6.466
Helicobacter pylori infection and fasting plasma glucose concentration
Abstract
Background: Helicobacter pylori infection raises basal and meal stimulated serum gastrin concentrations and lowers iron stores, which may in turn reduce fasting plasma glucose concentrations in the population.
Aim: To determine whether H pylori infection leads to lower fasting plasma glucose concentrations in the population.
Methods: One hundred and seventy three women and 165 men, randomly selected from the electoral rolls of an Australian city, participated in a cardiovascular risk factor survey. Plasma glucose concentrations and H pylori IgG antibody titres were measured. Non-fasting subjects and pregnant women were excluded, as were known diabetics, whose plasma glucose concentrations would be affected by diet and/or medications. Fasting plasma glucose concentrations were logarithmically transformed and the relation with H pylori infection, adjusting for age and other confounding factors, was determined for men and women separately by analyses of variance.
Results: Helicobacter pylori infection was significantly associated with fasting plasma glucose concentration among women. Infected women had a lower mean fasting plasma glucose concentration (5.2 mmol/litre; range, 3.9-8.2) than did non-infected women (5.4 mmol/litre; range, 3.9-11.1).
Conclusions: Helicobacter pylori infection may lead to lower fasting plasma glucose concentrations among women and should be considered when interpreting concentrations bordering on diabetes.
Similar articles
-
Impact of body mass index on fasting blood glucose concentration among Helicobater pylori carriers.Dig Dis. 2003;21(3):262-5. doi: 10.1159/000073345. Dig Dis. 2003. PMID: 14571101
-
Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria.World J Gastroenterol. 2013 Jan 7;19(1):97-102. doi: 10.3748/wjg.v19.i1.97. World J Gastroenterol. 2013. PMID: 23326169 Free PMC article.
-
Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.Am J Gastroenterol. 1999 Sep;94(9):2367-72. doi: 10.1111/j.1572-0241.1999.01359.x. Am J Gastroenterol. 1999. PMID: 10483993
-
Helicobacter pylori infection and diabetic complications.Diabetes Nutr Metab. 2004 Feb;17(1):65-8. Diabetes Nutr Metab. 2004. PMID: 15163129 Review. No abstract available.
-
Helicobacter pylori and diabetes mellitus: a controversial relationship.Minerva Endocrinol. 2019 Sep;44(3):301-309. doi: 10.23736/S0391-1977.19.03021-9. Minerva Endocrinol. 2019. PMID: 31304727 Review.
Cited by
-
Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study.Int J Diabetes Dev Ctries. 2010 Jan;30(1):22-6. doi: 10.4103/0973-3930.60008. Int J Diabetes Dev Ctries. 2010. PMID: 20431802 Free PMC article.
-
Proton pump inhibitors: impact on glucose metabolism.Endocrine. 2013 Feb;43(1):22-32. doi: 10.1007/s12020-012-9755-3. Epub 2012 Aug 12. Endocrine. 2013. PMID: 22886351 Review.
-
Epidemiology of Helicobacter pylori in Australia: a scoping review.PeerJ. 2022 May 31;10:e13430. doi: 10.7717/peerj.13430. eCollection 2022. PeerJ. 2022. PMID: 35669956 Free PMC article.
-
The effect of Helicobacter pylori on insulin resistance.Dig Dis Sci. 2005 Nov;50(11):2090-3. doi: 10.1007/s10620-005-3012-z. Dig Dis Sci. 2005. PMID: 16240220
-
Metabolic consequences of Helicobacter pylori infection and eradication.World J Gastroenterol. 2014 May 14;20(18):5226-34. doi: 10.3748/wjg.v20.i18.5226. World J Gastroenterol. 2014. PMID: 24833852 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical